84-1141-03　VEGFR-2, phosphorylated (Tyr996) (Vascular Endothelial Growth Factor Receptor 2, VEGFR-2, Kinase Insert Domain Receptor, Protein-tyrosine Kinase Receptor Flk-1, Fetal Liver Kinase 1, FLK-1, CD309 antigen, KDR, FLK1) 200ul　V2110-17F

特徴

• KDR (FLK1) is a receptor for VEGF or VEGFC.
• This protein has a tyrosine-protein kinase activity.
• The VEGF-kinase ligand/receptor signaling system plays a key role in vascular development and regulation of vascular permeability.
• Applications:Suitable for use in ELISA, Western Blot, and Immunohistochemistry.
• Other applications not tested.
• Recommended Dilution:ELISA: 1:1,000Western Blot: 1:100-1:500Immunohistochemistry: 1:50-1:100Optimal dilutions to be determined by the researcher.
• Storage and Stability:May be stored at 4°C for short-term only.
• Aliquot to avoid repeated freezing and thawing.
• Store at -20°C.
• Aliquots are stable for at least 12 months.
• For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

仕様

• Size：200ul
• Host：rabbit
• Source Antibody：human
• Grade：Affinity Purified
• Purity：Purified by immunoaffinity chromatography.
• Form：Supplied as a liquid in PBS, 0.09% sodium azide.
• Specificity：Recognizes human KDR when phosphorylated at Tyr996.
• Isotype：IgG
• Calc Applications Abbrev：E IHC WB
• Calc Crossreactivity：Hu
• Immunogen：Synthetic phosphopeptide corresponding to amino acid residues surrounding Tyr996 of human KDR/FLK1 (KLH).
• Shelf Life：1year
• Swiss Prot Number：P35968
• EU Commodity Code：30021010
• この商品は法規制を確認しておりません。（法規制によって販売できない場合もございます）
• 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。

• 【試薬に関するお問合せ】
• アズワン株式会社 試薬・プロセス材料グループ
• TEL：06-6447-8641
• FAX：06-6447-8642
• E-mail：[email protected]